Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.97% |
| 2 | Consumer Discretionary | 16.01% |
| 3 | Technology | 12.95% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Old Dominion Freight Line
ODFL
$46.3B
| $33.3M | 0.03% |
1,456,635
-2,005,938
| -58% | -$47.7M |
|
|
PLCM
402
DELISTED
POLYCOM INC
PLCM
| $33.2M | 0.03% |
2,901,425
-1,007,986
| -26% | -$13.2M |
|
|
INN
403
Summit Hotel Properties
INN
$766M
| $32.9M | 0.03% |
2,532,266
+391,594
| +18% | +$5.21M |
|
|
ESRX
404
DELISTED
Express Scripts Holding Company
ESRX
| $32.2M | 0.03% |
+361,685
| New | +$31.6M |
|
405
Eagle Bancorp
EGBN
$850M
| $31.9M | 0.03% |
725,157
+290,101
| +67% | +$11.6M |
|
406
Atara Biotherapeutics
ATRA
$72.6M
| $31.6M | 0.03% |
23,979
+189
| +0.8% | +$217K |
|
407
CDW
CDW
$18.9B
| $31.6M | 0.03% |
922,594
+627,926
| +213% | +$23.4M |
|
408
BOK Financial
BOKF
$8.58B
| $31.2M | 0.03% |
448,567
+16,099
| +4% | +$1.05M |
|
|
UNVR
409
DELISTED
Univar Solutions Inc.
UNVR
| $31.1M | 0.03% |
+1,196,110
| New | +$31.5M |
|
|
PINC
410
DELISTED
Premier
PINC
| $30.8M | 0.03% |
800,513
-83,318
| -9% | -$3.13M |
|
411
Prosperity Bancshares
PB
$8.9B
| $30.3M | 0.03% |
524,746
-238,610
| -31% | -$13M |
|
|
PTLA
412
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $29.6M | 0.03% |
649,900
+6,543
| +1% | +$263K |
|
413
Wheaton Precious Metals
WPM
$49.7B
| $29.2M | 0.03% |
1,685,342
+7,412
| +0.4% | +$142K |
|
414
Benchmark Electronics
BHE
$2.66B
| $29.1M | 0.03% |
1,338,141
-25,109
| -2% | -$595K |
|
415
Insmed
INSM
$22.4B
| $28.6M | 0.03% |
1,171,996
+8,440
| +0.7% | +$192K |
|
416
Cogent Communications
CCOI
$635M
| $28.3M | 0.03% |
835,694
-186,475
| -18% | -$6.25M |
|
|
TAHO
417
DELISTED
Tahoe Resources Inc
TAHO
| $28.1M | 0.03% |
2,316,999
+826,489
| +55% | +$11M |
|
418
Caesarstone
CSTE
$69.5M
| $28M | 0.03% |
+408,813
| New | +$25.3M |
|
|
CMO
419
DELISTED
Capstead Mortgage Corp.
CMO
| $28M | 0.03% |
2,520,256
+208,411
| +9% | +$2.46M |
|
|
STKL
420
DELISTED
SunOpta
STKL
| $27.9M | 0.03% |
2,602,543
+1,253,084
| +93% | +$13.2M |
|
421
Core Laboratories
CLB
$455M
| $27.9M | 0.03% |
244,276
+241
| +0.1% | +$29.2K |
|
422
Heartland Express
HTLD
$1.01B
| $27.7M | 0.03% |
1,370,727
-895,745
| -40% | -$19.2M |
|
|
GWPH
423
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27.5M | 0.03% |
223,805
-80,391
| -26% | -$9.12M |
|
|
PFPT
424
DELISTED
Proofpoint, Inc.
PFPT
| $27.4M | 0.03% |
430,078
-3,616
| -0.8% | -$213K |
|
425
DexCom
DXCM
$29B
| $27.3M | 0.03% |
1,364,212
+1,199,904
| +730% | +$21.1M |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.